Alteco Medical AB (NGM: ALTE)

Market Cap	16.83M
Revenue (ttm)	3.41M
Net Income (ttm)	-7.14M
Shares Out	107.19M
EPS (ttm)	-0.13
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,000
Open	0.120
Previous Close	0.142
Day's Range	0.120 - 0.120
52-Week Range	0.089 - 0.550
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 8, 2024

About Alteco Medical AB

Alteco Medical AB, a medical device company, provides technology for blood purification during extracorporeal treatment. Its product portfolio includes Alteco LPS Adsorber, which removes endotoxin from the bloodstream. Alteco Medical AB was founded in 2002 and is based in Lund, Sweden.

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2002
• Employees: 4
• Stock Exchange: Nordic Growth Market
• Ticker Symbol: ALTE

Financial Performance

In 2023, Alteco Medical AB's revenue was 6.06 million, a decrease of -26.23% compared to the previous year's 8.22 million. Losses were -6.16 million, 5.55% more than in 2022.